| 000 | 01819 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513101622.0 | ||
| 264 | 0 | _c19961203 | |
| 008 | 199612s 0 0 eng d | ||
| 022 | _a0269-9370 | ||
| 024 | 7 |
_a10.1097/00002030-199602000-00005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMerigan, T C | |
| 245 | 0 | 0 |
_aThe prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentin. _h[electronic resource] |
| 260 |
_bAIDS (London, England) _cFeb 1996 |
||
| 300 |
_a159-65 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAntigen-Antibody Complex |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Core Protein p24 _xblood |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV Reverse Transcriptase _xgenetics |
| 650 | 0 | 4 | _aHIV-1 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aRNA, Viral _xblood |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aThymopentin _xtherapeutic use |
| 650 | 0 | 4 | _aViral Load |
| 650 | 0 | 4 |
_aZidovudine _xtherapeutic use |
| 700 | 1 | _aHirsch, R L | |
| 700 | 1 | _aFisher, A C | |
| 700 | 1 | _aMeyerson, L A | |
| 700 | 1 | _aGoldstein, G | |
| 700 | 1 | _aWinters, M A | |
| 773 | 0 |
_tAIDS (London, England) _gvol. 10 _gno. 2 _gp. 159-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002030-199602000-00005 _zAvailable from publisher's website |
| 999 |
_c8832891 _d8832891 |
||